Fundamental dimension Equity attribute | STLDLeader $244.66▲+1.98% Cap $35.07BP/E 18.0x QuantScore64/100 | ASTLPeer $4.74▲+3.27% Cap $500.8MP/E -0.6x QuantScore51/100 | BLSFYPeer $109.400.00% Cap $10.08BP/E 17.7x QuantScore57/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
95/100 |
84/100 |
94/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | 33/100 | 60/100 |
Health Piotroski, Altman Z, leverage & liquidity | 92/100 | 20/100 | 68/100 |
Growth Revenue / earnings growth & margins | 24/100 | 16/100 | 30/100 |
Sentiment Analyst ratings, targets & revisions | 44/100 | 100/100 | 33/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 18.0x | -0.6x | 17.7x |
Forward P/E (next FY) | 13.8x | 4.0x | 7.8x |
EV / EBITDA (TTM) | 11.0x | -3.8x | 8.7x |
Price / Sales | 1.6x | 0.5x | 0.9x |
Price / Free Cash Flow | 32.0x | -1.9x | 54.8x |
PEG ratio | 0.22 | 0.01 | 0.02 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 2 / 9 | 7 / 9 |
Altman Z-Score | 6.05 (Safe) | -0.73 (Distress) | 3.63 (Safe) |
Total debt / equity | 0.43 | 3.68 | 0.17 |
Quick ratio | 1.5x | 1.3x | 1.0x |
Interest coverage | 19.3x | -16.8x | 11.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +3.6% | +22.3% | +0.3% |
Net income growth YoY | -22.9% | -536.5% | +836.1% |
Gross margin (TTM) | 15.8% | -46.9% | 13.6% |
Operating margin (FY) | 8.1% | -37.3% | 6.0% |
FCF margin (FY) | 2.8% | -18.9% | 1.6% |
5. Trailing price performancePrice change over period |
1M return | +2.7% | +13.1% | -2.1% |
3M return | -2.3% | +9.7% | +2.3% |
6M return | +6.5% | +4.9% | +1.9% |
Year to date | +42.5% | +15.6% | +38.5% |
1Y return | +57.9% | +5.3% | +58.2% |
3Y return | +137.7% | -30.2% | +88.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $94.93 -61.2% premium | $-8.56 -280.6% premium | $69.56 -36.4% premium |
Wall Street consensus target | $275.17 +12.5% · range $260.00–$299.00 | — — | — — |
Consensus stance | 52% Buy44% Hold4% Sell | 100% Buy0% Hold0% Sell | 50% Buy50% Hold0% Sell |